Hospital M&A Rebounds in 2026 as Healthier Sellers Demand Control
Becker's Hospital Review reports that hospital M&A volume has sharply rebounded in 2026, with 18 deals announced in Q2 alone compared to eight a year earlier, and transacted revenue jumping to $7.7 billion from $1.4 billion. Unlike the pandemic-era wave of financially distressed sellers, most current deals involve "strategically impaired" systems that are stable but lack capital to invest, giving their boards leverage to negotiate retained local control or management agreements rather than outright acquisitions. This complicates buyer underwriting and has caused some deals to collapse late in negotiations once true control terms become clear. Buyers are also modeling the impact of federal Medicaid reductions under H.R. 1 on target valuations, while state regulators in Minnesota and North Carolina have flagged pending mergers for closer review.